PlainRecalls
FDA Devices Moderate Class II Terminated

ACCESS SARS-CoV-2 ANTIGEN EXTRACTION SOLUTION, CONTENTS: 6 x 6.0 mL EXTRACTION SOLN, IVD, Rx Only, UDI: (01)15099590743017

Reported: August 18, 2021 Initiated: July 1, 2021 #Z-2258-2021

Product Description

ACCESS SARS-CoV-2 ANTIGEN EXTRACTION SOLUTION, CONTENTS: 6 x 6.0 mL EXTRACTION SOLN, IVD, Rx Only, UDI: (01)15099590743017

Reason for Recall

SARS-CoV-2 Antigen Assay test may generate false positive results which could result in incorrect diagnosis .

Details

Recalling Firm
Beckman Coulter Inc.
Units Affected
3,672 unitsin total
Distribution
US Nationwide Distribution in the states of Alabama Alaska Arizona Arkansas California Connecticut Delaware Florida Georgia Idaho Illinois Indiana Iowa Kentucky Louisiana Maine Maryland Massachusetts Michigan Mississippi New Hampshire New Jersey New York North Carolina Ohio Oklahoma Oregon Pennsylvania Puerto Rico Tennessee Texas Virginia West Virginia, Wisconsin OUS: New Zealand, Libya
Location
Brea, CA

Frequently Asked Questions

What product was recalled?
ACCESS SARS-CoV-2 ANTIGEN EXTRACTION SOLUTION, CONTENTS: 6 x 6.0 mL EXTRACTION SOLN, IVD, Rx Only, UDI: (01)15099590743017. Recalled by Beckman Coulter Inc.. Units affected: 3,672 unitsin total.
Why was this product recalled?
SARS-CoV-2 Antigen Assay test may generate false positive results which could result in incorrect diagnosis .
Which agency issued this recall?
This recall was issued by the FDA Devices on August 18, 2021. Severity: Moderate. Recall number: Z-2258-2021.